Injectable Poly-l-Lactic Acid for Body Aesthetic Treatments: An International Consensus on Evidence Assessment and Practical Recommendations

臀部 医学 返老还童 面部修复 整形外科 观察研究 脂肪团 循证医学 美容技术 耳鼻咽喉科 外科 替代医学 病理 蜂窝织炎
作者
Alessandra Haddad,Luiz Eduardo Toledo Avelar,Sabrina G. Fabi,Juliana Sarubi,Michael Somenek,Daniel Dal’Asta Coimbra,Melanie D. Palm,K Kay Durairaj,Munir Somji,Roberta Vasconcelos‐Berg,Lim Hanseok,Kate Morlet-Brown,Jeff Huang,Rebecca C. Fitzgerald,Dóris Hexsel,Cheng Jie Mao,Felipe Weinberg,Inna Prygova,Daniel Bråsäter
出处
期刊:Aesthetic Plastic Surgery [Springer Nature]
标识
DOI:10.1007/s00266-024-04499-9
摘要

Abstract Non-facial (body) rejuvenation is a treatment of increasing demand, with patients seeking to harmonize the benefits of rejuvenated facial appearance with other areas of the body. Poly- l -lactic acid (PLLA)-SCA (Sculptra®) has been approved for facial aesthetic uses since 1999 in Europe and since 2009 in the USA and more recently evaluated for the treatment of cellulite of the buttocks and thighs and other body indications. The current evidence base consists largely of prospective observational analyses and case series although systematic evaluations for a number of body areas are underway. Current data support a potential benefit for the use of PLLA-SCA for the aesthetic treatment of the neck, knees, abdomen, hands and upper arms. Improvements in aesthetic appearance (e.g. sagging, wrinkling, dimpling, cellulite) that are sustained over time with minimal side effects can be achieved. Standardization of injection protocols for different body areas is now needed along with the validation of clinical tools that can be used to agree on treatment goals and to evaluate aesthetic improvements over time. A group of international experts in the fields of facial and body aesthetics, plastic surgery and dermatology were selected based on their educational, scientific and publication merits together with clinical experience using PLLA-SCA for body rejuvenation. Here, we provide an evidence-based and expert-led consensus (14 years of off-face treatment experience) on recommendations for appropriate injection protocols for different body sites and evaluation tools when using the biostimulator PLLA-SCA for body aesthetic and rejuvenation procedures. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
man应助科研通管家采纳,获得10
刚刚
Renhong应助科研通管家采纳,获得10
1秒前
无花果应助科研通管家采纳,获得10
1秒前
xjcy应助科研通管家采纳,获得10
1秒前
顾矜应助科研通管家采纳,获得10
1秒前
pluto应助科研通管家采纳,获得10
1秒前
pluto应助科研通管家采纳,获得20
1秒前
1秒前
程勋航发布了新的文献求助10
1秒前
桐桐应助科研通管家采纳,获得10
1秒前
1秒前
脑洞疼应助科研通管家采纳,获得10
1秒前
FashionBoy应助科研通管家采纳,获得10
1秒前
man应助科研通管家采纳,获得10
2秒前
星辰大海应助科研通管家采纳,获得10
2秒前
xjcy应助科研通管家采纳,获得10
2秒前
乐乐应助科研通管家采纳,获得10
2秒前
NexusExplorer应助科研通管家采纳,获得10
2秒前
爆米花应助科研通管家采纳,获得10
2秒前
共享精神应助科研通管家采纳,获得30
2秒前
李健应助科研通管家采纳,获得10
2秒前
情怀应助正直的沛凝采纳,获得10
2秒前
orixero应助科研通管家采纳,获得10
2秒前
科目三应助科研通管家采纳,获得10
2秒前
华仔应助科研通管家采纳,获得10
2秒前
所所应助科研通管家采纳,获得10
2秒前
3秒前
man应助科研通管家采纳,获得10
3秒前
永曼发布了新的文献求助10
3秒前
真巧发布了新的文献求助10
3秒前
不倦应助欸嘿采纳,获得10
4秒前
林小昀完成签到 ,获得积分10
6秒前
silin完成签到,获得积分10
6秒前
椒花颂声完成签到,获得积分20
10秒前
11秒前
13秒前
14秒前
爆米花应助缥缈的平露采纳,获得10
14秒前
15秒前
椒花颂声发布了新的文献求助10
16秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
Geochemistry, 2nd Edition 地球化学经典教科书第二版,不要epub版本 431
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 400
The Conscience of the Party: Hu Yaobang, China’s Communist Reformer 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3292581
求助须知:如何正确求助?哪些是违规求助? 2928881
关于积分的说明 8438815
捐赠科研通 2600953
什么是DOI,文献DOI怎么找? 1419350
科研通“疑难数据库(出版商)”最低求助积分说明 660282
邀请新用户注册赠送积分活动 642924